Page
%P
-
Article
Open AccessNeoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
At diagnosis, tumor-infiltrating lymphocytes (TILs) are prognostic in epithelial ovarian cancer (EOC). We recently demonstrated that neoadjuvant chemotherapy (NACT) significantly increased stromal TILs. Here,...
-
Article
Open AccessThe PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
The phosphatidylinositol 3 kinase (PI3K) pathway is frequently altered in cancer, including ovarian cancer (OC). Unfortunately, despite a sound biological rationale and encouraging activity in preclinical mode...